Ocular surface discomfort is often attributed to the symptoms of dry eye, but conditions affecting the lacrimal gland are uncommon. Meibomian gland dysfunction (MGD) is extremely common and is a characteristic feature of many patients with dry eye symptoms. Most ophthalmologists choose some type of lubricant artificial tear drop as first-line treatment for dry eye symptoms, but this paper questions the rationale for this decision. Patients who can cry, or produce tears from any stimulus, demonstrate lacrimal gland function. This paper considers the rationale for employing a safe, effective, biodegradable warm compress as first-line treatment for MGD and associated dry eye symptoms.
Dry eye, meibomian gland dysfunction, Sjögren syndrome, blepharitis, warm compress, EyeBag®, anthropocene
Compliance with Ethics: This study involves a review of the literature and did not involve any studies with human or animal subjects performed by any of the authors. All images published with full patient consent and permissions. All photographs taken by the author.
Double-blind peer review.
The named authors meets the International
Committee of Medical Journal Editors (ICMJE) criteria
for authorship of this manuscript, takes responsibility
for the integrity of the work as a whole, and has given
final approval for the version to be published.
Teifi James, The EyeBag Company, Unit 5, Calderdale Business Park, Club Lane. Halifax, West Yorkshire, HX2 8DB, UK. E: firstname.lastname@example.org
No funding was received for the publication of this article.
18 November 2019
Share this Article
Related Content In Ocular Surface Disease
The Role of Biofilms in Pathology of the Ocular Surface
touchREVIEWS in Ophthalmology. 2021;15(1):12–14. DOI: https://doi.org/10.17925/OPHT.2021.15.1.12
Over the past few years, we have witnessed an increasing awareness of the importance of treating ocular surface disease (OSD). Diagnoses such as dry eye and blepharitis, which were historically under-appreciated, now command attention from the ophthalmologist and investment from the ocular pharmaceutical industry. Proper treatment of the ocular surface is paramount to the health […]
Tear Film Biomarkers in Dry Eye Disease
US Ophthalmic Review. 2020;13(2):68-72 DOI: https://doi.org/10.17925/USOR.2020.13.2.68
Dry eye disease is a chronic condition that affects the corneal surface, and is clinically characterized by loss of tear volume and increased evaporation of tears.1,2 The definition of dry eye disease has evolved since it was first recognized over 30 years ago, with advanced research resulting in a better understanding of the disease pathophysiology.3 The official […]
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!